News Releases

AVON, Conn.--(BUSINESS WIRE)-- Magellan Health Services, Inc. (NASDAQ: MGLN) announced today that René Lerer, Chairman and Chief Executive Officer of the Company, will present at two upcoming investor conferences:

• The Raymond James 33rd Annual Institutional Investor Conference on Tuesday, March 6, 2012, 2:50 p.m. Eastern time in Orlando, FL at the JW Marriott Grande Lakes Hotel.
• The Barclays Capital 2012 Global Healthcare Conference on Wednesday, March 14, 2012, 1:30 p.m. Eastern time in Miami, FL at the Loews Miami Hotel.

Investors and the public are invited to access audio and presentation materials through Magellan's investor relations page at www.MagellanHealth.com. Those who plan to access the webcasts should log on to the website approximately 15 minutes before the scheduled start time of the conference to register and download and install any necessary software. The audio will be available for one week following each presentation.

Those who plan to access the webcasts are encouraged to read Magellan's Annual Report on Form 10-K for the year ended 2011, to be filed with the Securities and Exchange Commission prior to the conference, for material information regarding Magellan's operational and financial results, including the section entitled "Risk Factors."

About Magellan: Headquartered in Avon, Conn., Magellan Health Services, Inc. is a leading specialty health care management organization with expertise in managing behavioral health, radiology and specialty pharmaceuticals, as well as public sector pharmacy benefits programs. Magellan delivers innovative solutions to improve quality outcomes and optimize the cost of care for those we serve. As of September 30, 2011, Magellan's customers included health plans, employers and government agencies, serving approximately 31.2 million members in our behavioral health business, 16.3 million members in our radiology benefits management segment, and 5.5 million members in our medical pharmacy management product. In addition, the specialty pharmaceutical segment served 41 health plans and several pharmaceutical manufacturers and state Medicaid programs. The company's Medicaid Administration segment served 25 states and the District of Columbia. For more information, visit www.MagellanHealth.com.

Cautionary Statement: Certain of the statements made in the presentations may constitute forward-looking statements contemplated under the Securities Exchange Act of 1934 and the Securities Act of 1933, as amended, that involve a number of risks and uncertainties. These forward-looking statements are based on management's analysis, judgment, belief and expectations as of the date of such statements and are subject to known and unknown uncertainties and risks which could cause actual results to differ materially from those contemplated or implied by such forward-looking statements. Any forward-looking statements made in the presentations are qualified in their entirety by the more complete discussion of risks set forth in the section entitled "Risk Factors" in Magellan's most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, filed with the Securities and Exchange Commission. Magellan undertakes no obligation to publicly revise such forward looking statements to reflect events or circumstances that arise after the date of such statements.

Magellan Health Services, Inc.
Media Contact:
David W. Carter, 860-507-1909
dwcarter@magellanhealth.com
or
Investor Contact:
Renie Shapiro, 877-645-6464
rshapiro@magellanhealth.com

Source: Magellan Health Services, Inc.

News Provided by Acquire Media